A thematic series published in Allergy, Asthma & Clinical Immunology
This series is meant to review the current international consensus approach for the diagnosis, therapy, and management of hereditary angioedema. The Toronto Consensus meeting was sponsored by the Canadian Hereditary Angioedema Network, the Canadian Society of Allergy and Clinical Immunology and the University of Calgary and supported through an unrestricted educational grant from CSL Behring. The contributed manuscripts and publication of the Consensus were supported by the Canadian Hereditary Angioedema Network and various author university affiliations.
View all article collections published in Allergy, Asthma & Clinical Immunology